Evidence map›Paper›PMID 40914335›Full record

ArticlePharmacology, biochemistry, and behavior2025

Swiss-Webster and C57BL/6 mice are differentially sensitive to the stimulant effects of methamphetamine.

Bo Jarrett Wood, Nicole M Hall, M Frances Vest, Papori Sharma, Kevin S Murnane

Abstract read
In one paragraph

Article in Pharmacology, biochemistry, and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bo Jarrett WoodDepartment of Pharmacology, Toxicology & Neuroscience, School of Graduate Studies, Louisiana State University Health Shreveport - Shreveport, Louisiana, USA; Louisiana Addiction Research Center, Louisiana State University Health Shreveport - Shreveport, Louisiana, USA.
Nicole M HallDepartment of Pharmacology, Toxicology & Neuroscience, School of Graduate Studies, Louisiana State University Health Shreveport - Shreveport, Louisiana, USA; Louisiana Addiction Research Center, Louisiana State University Health Shreveport - Shreveport, Louisiana, USA.
M Frances VestDepartment of Pharmacology, Toxicology & Neuroscience, School of Graduate Studies, Louisiana State University Health Shreveport - Shreveport, Louisiana, USA; Louisiana Addiction Research Center, Louisiana State University Health Shreveport - Shreveport, Louisiana, USA.
Papori SharmaDepartment of Pharmacology, Toxicology & Neuroscience, School of Graduate Studies, Louisiana State University Health Shreveport - Shreveport, Louisiana, USA; Louisiana Addiction Research Center, Louisiana State University Health Shreveport - Shreveport, Louisiana, USA.
Kevin S MurnaneDepartment of Pharmacology, Toxicology & Neuroscience, School of Graduate Studies, Louisiana State University Health Shreveport - Shreveport, Louisiana, USA; Louisiana Addiction Research Center, Louisiana State University Health Shreveport - Shreveport, Louisiana, USA; Department of Psychiatry and Behavioral Medicine, School of Medicine, Louisiana State University Health Shreveport - Shreveport, Louisiana, USA. Electronic address: kevin.murnane@lsuhs.edu.

Funding

Stress Exacerbates Myocardial Ischemic Injury by Blocking Estrogen's Antidoxidant Protection in the Female HeartP20GM121307 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Vesna Tesic · 2018 to 2026
$23.6M
Exploring the role of oxytocin in the regulation of neuronal excitabilityR01NS120676 · NINDS · EMORY UNIVERSITY · PI ESCAYG, ANDREW P, MURNANE, KEVIN SEAN · 2021 to 2025
$2.4M
Investigations into 5-HT2A signaling mechanisms of psychedelic drugs for the treatment of stimulant use disorderR01DA061433 · NIDA · MEDICAL COLLEGE OF WISCONSIN · PI ADAM L. Halberstadt, John D McCorvy · 2024 to 2026
$1.5M
Multidisciplinary Training in Cardiovascular PathophysiologyT32HL155022 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ORR, ANTHONY WAYNE, STOKES, KAREN Y · 2021 to 2025
$619k
Immunotherapeutic Targeting CD74 as a Treatment for Stimulant Use DisorderR41DA059296 · NIDA · VIROGENOMICS BIODEVELOPMENT, INC. · PI LOFTIS, JENNIFER M, MURNANE, KEVIN SEAN · 2024 to 2024
$405k
NHLBI NIH HHS T32 HL155022NIDA NIH HHS R01 DA061433NIDA NIH HHS R41 DA059296NIGMS NIH HHS P20 GM121307NINDS NIH HHS R01 NS120676
6 · The paper itself

Abstract

Methamphetamine is a highly addictive psychostimulant with significant neurobiological consequences, yet strain-dependent differences in its effects remain poorly understood. This study investigated behavioral and molecular differences in Swiss-Webster and C57BL/6 mice following methamphetamine exposure. Swiss-Webster mice exhibited greater behavioral sensitivity to methamphetamine compared to C57BL/6 mice, as demonstrated by lower peak doses required to elicit locomotor stimulation and conditioned place preference. Gene expression analyses revealed significantly higher striatal dopamine D2 receptor mRNA levels in Swiss-Webster mice, alongside a main effect of strain across multiple dopaminergic receptors, suggesting broader transcriptional differences may contribute to their heightened behavioral response. However, no strain differences were observed in dopamine transporter or dopamine D1 receptor mRNA expression. Following a neurotoxic binge-dosing regimen, both strains showed significant dopamine depletion, but no differences in the dopamine metabolite DOPAC were observed between strains in the striatum. Given the role of dopaminergic signaling in stimulant sensitivity and reward, these findings suggest that strain-dependent differences in methamphetamine response may reflect broader alterations in dopamine system function between these strains. This is the first study to directly compare Swiss-Webster and C57BL/6 mice in methamphetamine-induced CPP and provides novel insight into strain-specific drug reward mechanisms.

Indexed as

Central Nervous System StimulantsMethamphetamineAnimalsBehavior, AnimalCorpus StriatumDopamineDopamine Plasma Membrane Transport ProteinsMaleMiceMice, Inbred C57BLReceptors, Dopamine D1Receptors, Dopamine D2Species SpecificityCentral Nervous System StimulantsDopamineDopamine Plasma Membrane Transport ProteinsMethamphetamineReceptors, Dopamine D1Receptors, Dopamine D2addictionC57BL/6dopamine receptormethamphetaminestrain-differencesSwiss-Webster

Identifiers

PMID40914335
PMCPMC13648124

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.